Type a ticker — we pressure-test it against live facts, filings, and sentiment.
Amgen Inc. — Healthcare · Drug Manufacturers—General carries a Plainview business-quality score of 7.8/10, built deterministically from SEC filings and Yahoo Finance: revenue, margins, cash, valuation, and a confluence buy zone. The live X-Ray loads below.
On the fundamentals, Amgen Inc. shows trailing revenue of $37.22B, a 71.4% gross margin, net debt of $39.85B, EPS of 15.18, valued at about 5.6x times sales. X-Ray measures business quality only — momentum and entry timing live in Decide and Opportunity Cost.
Compare: AMGN vs UNH · AMGN vs JNJ · AMGN vs LLY | Also: UNH, JNJ, LLY, PFE, MRK, ABBV